{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:03:08Z","timestamp":1785254588514,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijom.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:38:50Z","timestamp":1776857930000},"page":"999-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relevance of tumour-infiltrating lymphocytes in oral mucosal melanoma: a systematic review"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-9252","authenticated-orcid":false,"given":"C.F.J.","family":"Bakhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-8267","authenticated-orcid":false,"given":"E.J.","family":"de Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-5814","authenticated-orcid":false,"given":"R.","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-3667","authenticated-orcid":false,"given":"G.E.","family":"Breimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-5074","authenticated-orcid":false,"given":"E.M.","family":"Van Cann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijom.2026.04.006_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.oraloncology.2008.04.015","article-title":"Primary oral melanoma: population-based incidence","volume":"45","author":"Sortino-Rachou","year":"2009","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.ijom.2026.04.006_bib2","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/j.jormas.2022.02.002","article-title":"Oral mucosal melanoma\u2014a systematic review","volume":"123","author":"Thuaire","year":"2022","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"8","key":"10.1016\/j.ijom.2026.04.006_bib3","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/cam4.3789","article-title":"Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade","volume":"10","author":"Buchbinder","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijom.2026.04.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.106807","article-title":"Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort","volume":"152","author":"Ichimura","year":"2024","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2026.04.006_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2020.05.021","article-title":"Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands\u2014a nationwide population-based study","volume":"137","author":"Van Zeijl","year":"2020","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ijom.2026.04.006_bib6","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.humpath.2013.01.025","article-title":"Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations","volume":"44","author":"Chraybi","year":"2013","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.ijom.2026.04.006_bib7","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.oooo.2011.11.034","article-title":"Oral malignant melanoma: systematic review of literature and report of two cases","volume":"116","author":"Mohan","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"10.1016\/j.ijom.2026.04.006_bib8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(19850401)55:7<1543::AID-CNCR2820550722>3.0.CO;2-F","article-title":"Primary malignant melanoma of the oral cavity. A review of 177 cases","volume":"55","author":"Rapini","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ijom.2026.04.006_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2407-11-85","article-title":"Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases","volume":"11","author":"Chi","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ijom.2026.04.006_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1368-8375(99)00085-8","article-title":"Oral mucosal melanoma: epidemiology and pathobiology","volume":"36","author":"Hicks","year":"2000","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.ijom.2026.04.006_bib11","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijom.2026.04.006_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.5808","article-title":"Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations","volume":"256","author":"Jurmeister","year":"2022","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ijom.2026.04.006_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/path.5017","article-title":"Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets","volume":"244","author":"Lyu","year":"2018","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ijom.2026.04.006_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CMR.0000000000000345","article-title":"Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma","volume":"27","author":"Hintzsche","year":"2017","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.ijom.2026.04.006_bib15","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.ijom.2026.04.006_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bjoms.2020.05.028","article-title":"Survival of oral mucosal melanoma according to treatment, tumour resection margin, and metastases","volume":"58","author":"Chae","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.ijom.2026.04.006_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.oraloncology.2012.01.019","article-title":"Treatment and prognosis of oral mucosal melanoma","volume":"48","author":"Sun","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2026.04.006_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.oraloncology.2018.10.022","article-title":"The existence of early stage oral mucosal melanoma: a 10-year retrospective analysis of 170 patients in a single institute","volume":"87","author":"Wu","year":"2018","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.ijom.2026.04.006_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"International TILs Working Group 2014. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ijom.2026.04.006_bib20","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/cancers14061558","article-title":"Tumor-infiltrating lymphocytes in head and neck cancer: ready for prime time?","volume":"14","author":"Almangush","year":"2022","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.ijom.2026.04.006_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.2024.3056","article-title":"International Immuno-Oncology Biomarker Working Group. Tumor-infiltrating lymphocytes in triple-negative breast cancer","volume":"331","author":"Leon-Ferre","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijom.2026.04.006_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1593806","article-title":"Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis","volume":"8","author":"Fu","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijom.2026.04.006_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114190","article-title":"Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma","volume":"208","author":"Van Duin","year":"2024","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ijom.2026.04.006_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ijom.2026.04.006_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154342","article-title":"Clinical significance of overall assessment of tumor-infiltrating lymphocytes in oropharyngeal cancer: a meta-analysis","volume":"243","author":"Almangush","year":"2023","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.ijom.2026.04.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117544","article-title":"The prognostic value of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"180","author":"Torri","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijom.2026.04.006_bib27","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ijom.2026.04.006_bib28","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"4","key":"10.1016\/j.ijom.2026.04.006_bib29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/his.12692","article-title":"Prognostic factors of oral mucosal melanoma: histopathological analysis in a retrospective cohort of 82 cases","volume":"67","author":"Song","year":"2015","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ijom.2026.04.006_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/CAD.0000000000000454","article-title":"Optimal multidisciplinary treatment of oral cavity mucosal melanoma: outcome analysis in a case series","volume":"28","author":"Perri","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijom.2026.04.006_bib31","series-title":"American joint committee on cancer staging manual","first-page":"97","author":"Edge","year":"2009"},{"key":"10.1016\/j.ijom.2026.04.006_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.524700","article-title":"Poor lymphocyte infiltration to primary tumors in acral lentiginous melanoma and mucosal melanoma compared to cutaneous melanoma","volume":"10","author":"Nakamura","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ijom.2026.04.006_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CMR.0000000000000620","volume":"30","author":"Ren","year":"2020","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.ijom.2026.04.006_bib34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1158\/2767-9764.CRC-23-0406","article-title":"Comparative epigenetic profiling reveals distinct features of mucosal melanomas associated with immune cell infiltration and their clinical implications","volume":"4","author":"Dai","year":"2024","journal-title":"Cancer Res Commun"},{"issue":"2","key":"10.1016\/j.ijom.2026.04.006_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.annonc.2023.10.793","article-title":"Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma","volume":"35","author":"Lian","year":"2024","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ijom.2026.04.006_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004879","article-title":"Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study","volume":"10","author":"Shui","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.ijom.2026.04.006_bib37","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s10147-022-02189-7","article-title":"Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+\u2009and CD8+\u2009T cells in Japanese melanoma patients","volume":"27","author":"Yoneta","year":"2022","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ijom.2026.04.006_bib38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/lary.29820","article-title":"Prognostic value of tumor-infiltrating lymphocytes in sinonasal mucosal melanoma","volume":"132","author":"Ledderose","year":"2022","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.ijom.2026.04.006_bib39","first-page":"115","article-title":"Prognostic significance of tumor-infiltrating lymphocytes and anti-programmed death-ligand 1 therapy in sinonasal mucosal melanoma: a 10-year experience at a single institution","volume":"3","author":"Tarabay","year":"2023","journal-title":"J Clin Transl Pathol"},{"issue":"12","key":"10.1016\/j.ijom.2026.04.006_bib40","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/lary.30240","article-title":"Sinonasal mucosal melanoma: role of tumor proliferative indices and pathological factors in survival","volume":"132","author":"Guo","year":"2022","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.ijom.2026.04.006_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pcmr.12185","article-title":"Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma","volume":"27","author":"Simpson","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.ijom.2026.04.006_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0300985821999321","article-title":"Intratumoral T-lymphocyte subsets in canine oral melanoma and their association with clinical and histopathological parameters","volume":"58","author":"Yasumaru","year":"2021","journal-title":"Vet Pathol"},{"key":"10.1016\/j.ijom.2026.04.006_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104719","article-title":"Concordance of tumor infiltrating lymphocytes, PD-L1 and p16 expression in small biopsies, resection and lymph node metastases of oropharyngeal squamous cell carcinoma","volume":"106","author":"Brcic","year":"2020","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.ijom.2026.04.006_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CJI.0000000000000282","article-title":"Combination nivolumab\/ipilimumab immunotherapy for melanoma with subsequent unexpected cardiac arrest: a case report and review of literature","volume":"42","author":"Khoury","year":"2019","journal-title":"J Immunother"},{"key":"10.1016\/j.ijom.2026.04.006_bib45","article-title":"Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma","volume":"24","author":"van Duin","year":"2024","journal-title":"Immunooncol Technol"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502726001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502726001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:43:03Z","timestamp":1785253383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502726001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0901502726001487"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2026.04.006","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of tumour-infiltrating lymphocytes in oral mucosal melanoma: a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Association of Oral and Maxillofacial Surgeons.","name":"copyright","label":"Copyright"}]}}